Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Personalized treatment plans are important for people with alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tailoring COVID-19 measures to risk levels in the military improves health and readiness.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

Nanotechnology therapies can help improve quality of life for those with hair loss.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

No cure exists for alopecia areata, and treatments are personalized.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.